Pfizer’s hemophilia B gene therapy is better than standard of care in phase 3 trial
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
Early Win for Gene Therapy in Rare Form of SCID — 10 infants were able to make their own T cells; safety good so far
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
